STAT
JULY 25, 2024
UnitedHealth Group started out as a small, Minnesota health insurance company and has since morphed into a modern-day Standard Oil, exerting unmatched dominance over health care in the United States. It’s no secret that UnitedHealth is a colossus: It’s the country’s largest health insurer and the fourth-largest company of any type by revenue, just behind Apple.
PharmaVoice
JULY 25, 2024
A VC investor shares how the market is recovering, which kinds of companies he’s hunting for and where he’d love to see more innovation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 25, 2024
Breast cancer surgeons have tended not to push patients towards bilateral mastectomy, since data have long shown that the complete removal of both breasts doesn’t improve survival. New data from a large epidemiological study affirmed that, but an accompanying finding is puzzling. Breast cancer survivors who ended up developing a second breast cancer in the opposite or contralateral breast had a higher risk of death, even though preventing that cancer with surgery didn’t change outc
BioPharma Dive
JULY 25, 2024
Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors, as sales of Dupixent rose over the last quarter.
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
STAT
JULY 25, 2024
Many people were stunned when an FDA advisory committee voted “no” on a new drug application for MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) earlier this summer. I was not among them. Several things were stacked against approval: The FDA greenlights only about 50 new drugs each year. Drug development is a high-risk business with an overall success rate between 10% and 20%.
The Pharmacist
JULY 25, 2024
Everyone should have access to a full range of contraceptives in ‘the location of their choosing’, an open letter signed by the National Pharmacy Association (NPA) and the Royal Pharmaceutical Society (RPS) has urged. Dr Janet Barter, secretary of the Faculty of Sexual and Reproductive Health (FSRH), wrote to secretary of state Wes Streeting this […] The post Pharmacy bodies join calls for improved contraception access appeared first on The Pharmacist.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
JULY 25, 2024
Ipsen has signed yet another portfolio-expanding deal – its fifth of the year so far – claiming rights outside the US to a drug for common brain cancer glioma from Day One Biopharmaceuticals.
STAT
JULY 25, 2024
A little-known office within the Department of Health and Human Services is getting a shot in the arm as part of a major agency reorganization announced on Thursday. The Office of the National Coordinator for Health Information Technology, better known as ONC, regulates data standards for health care systems, including the electronic health records that underpin patient care and billing.
pharmaphorum
JULY 25, 2024
There has been a gene therapy on the market for people with the bleeding disorder haemophilia A since 2022, but take-up has been very slow. Pfizer and Sangamo are hoping for a faster trajectory with their experimental treatment.The partners' one-shot giroctocogene fitelparvovec therapy has cleared a phase 3 trial, showing it was better than regular prophylaxis injections with Factor VIII (FVIII) replacement therapies at reducing bleeding episodes, and could now be heading for regulatory review.
STAT
JULY 25, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Welcome back! I’ve been working from home almost this entire summer because of construction on the Red Line. I hate the MBTA. Boston readers know what I mean. This week: “Muscarinics” are hot and Neurocrine Biosciences is the next biotech with a big study readout.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
JULY 25, 2024
NewAmsterdam Pharma has completed the enrollment of 407 patients in the pivotal Phase III TANDEM clinical trial evaluating obicetrapib in combination with ezetimibe in patients with heterozygous familial hypercholesterolemia (HeFH) and/or atherosclerotic cardiovascular disease (ASCVD). Obicetrapib has demonstrated strong tolerability in more than 800 patients with elevated lipid levels in NewAmsterdam’s clinical trials to date.
STAT
JULY 25, 2024
LONDON — In the booming field of weight loss drugs, Roche has been riding high in recent months, with back-to-back positive studies of two experimental medicines that sent the company’s shares up — and those of its rivals down. But on Thursday, company executives faced an onslaught of questions from analysts during an earnings presentation about what came next for the company’s weight loss drugs and how they would stand apart in the wildly competitive field.
pharmaphorum
JULY 25, 2024
Tune in to the Reverba podcast featuring CEO Cheryl Lubbert as she discusses patient engagement throughout the product lifecycle, sharing insights and strategies for success.
STAT
JULY 25, 2024
For Dr. Jeremy Faust, July 1 is like New Year’s Day. That’s when thousands of new medical school graduates enter teaching hospitals across the country and provide care to patients as doctors for the first time. “Everything is new and full of possibilities,” said Faust, an emergency physician at Brigham and Women’s Hospital.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
JULY 25, 2024
Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate the market.
STAT
JULY 25, 2024
It takes years for most people with a rare disease to learn what is ailing them. Their symptoms may be crystal clear, but the cause isn’t. Efforts by the Department of Justice — an agency not known for its medical expertise — will make things even harder for the millions of Americans , half of them children, with one of these diseases.
Drug Patent Watch
JULY 25, 2024
The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the crisis.
STAT
JULY 25, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Medicare regulators’ proposal to start paying for some digital therapeutics products created a wave of enthusiasm when it was released earlier this month.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
JULY 25, 2024
BSV’s 2500+ employees to join Mankind Pharma Ending months of speculation, Mankind Pharma announced a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines Limited (BSV) from PE investor Advent International, for an enterprise value of approx. Rs 13,630 crores, subject to closing related adjustments. The move will position Mankind Pharma as a market leader in India’s women’s health and fertility drug market alongside access to other high entry barrier pr
STAT
JULY 25, 2024
What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Tara Bannow, our hospitals and insurance reporter, joins us to talk about a new investigation that shows how UnitedHealth wields its unrivaled physician empire to boost its profits and expand its influence.
Outsourcing Pharma
JULY 25, 2024
Back in March this year (2024) under the last UK Conservative government, plans were announced to give greater powers to pharmacy technicians, dental therapists and hygienists after two public consultations.
STAT
JULY 25, 2024
Rise and shine, everyone, another busy day is on the way. We can tell because the pace of motor vehicles passing by our window is picking up and the official mascots are busy foraging for varmints passing through the campus grounds. As for us, we are engaged in the usual ritual of brewing cups of stimulation. Our choice today is strawberry cream. As always, you are invited to join us.
pharmaphorum
JULY 25, 2024
Exploring the impact of ageing on Europe and the need to prioritise neurological conditions. Understand the role of neuroscience in addressing these issues.
STAT
JULY 25, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Before we get to biotech, check out STAT’s deep dive into how UnitedHealth mobilizes a massive network of physicians and milked the health care system for profit.
Pharma Times
JULY 25, 2024
Conditions such as Alzheimer’s and Parkinson’s affect over one million people in the UK
Express Pharma
JULY 25, 2024
Mankind Pharma has entered into a definitive agreement to acquire a 100 per cent stake in Bharat Serums and Vaccines (BSV) from Advent International, for an enterprise value of approximately Rs 13,630 crores, subject to closing-related adjustments. With this acquisition, Mankind Pharma aims to further establish itself in the Indian women’s health and fertility drug market alongside access to other high entry barrier products in critical care with established complex R&D tech platforms.
pharmaphorum
JULY 25, 2024
NICE clears NHS use of Boehringer's clot-busting drug Metalyse for acute ischaemic stroke, saying it could 'save millions'
Pharmaceutical Technology
JULY 25, 2024
JNJ-2056 is being investigated in the Phase IIb ReTain study which enrols participants who are yet to show Alzheimer’s symptoms.
pharmaphorum
JULY 25, 2024
NICE clears NHS use of Boehringer's clot-busting drug Metalyse for acute ischaemic stroke, saying it could 'save millions'
Pharma Times
JULY 25, 2024
The research will help to better understand how this pathway is coordinated in the cell
pharmaphorum
JULY 25, 2024
Digital dementia detection specialist Linus Health has expanded its patient care focus with the acquisition of Together Senior Health.
Express Pharma
JULY 25, 2024
The AEO-LO certification will streamline clearance procedures for DP World at all customs stations across India for a period of five years. Rajesh Pandey, Chief Commissioner of Customs, Mumbai Zone-II, Jawaharlal Nehru Custom House (JNCH) handed over the certification to DP World, represented by Akash Agrawal, Vice-President, Freight Forwarding, India subcontinent.
pharmaphorum
JULY 25, 2024
European pharma groups AstraZeneca, Sanofi, and Roche all raise their financial guidance for the year on stronger sales growth.
Expert insights. Personalized for you.
364 
Let's personalize your content